Related Experiment Video
Updated: May 7, 2025

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
Published on: January 3, 2020
Malignant Insulinoma: Diagnostic Difficulties and Treatment Strategies in a Case of Persistent Hypoglycemia
Shubh Mehta1, Ahan Banker1, Jay V Shah1
1Department of Internal Medicine, B. J. Medical College and Civil Hospital, Ahmedabad, IND.
Abstract:
Hypoglycemia in non-diabetic individuals is a rare but critical condition that often signals an underlying pathology. Insulinoma, a rare neuroendocrine tumor of the pancreas, is a key differential diagnosis. As the most common functional pancreatic neuroendocrine tumors, insulinomas originate from pancreatic islet cells and are predominantly benign. However, malignant cases, although rare, represent a significant diagnostic challenge. Here, we report a 67-year-old female with recurrent hypoglycemic episodes presenting as diaphoresis and palpitations, alleviated by glucose intake. Initial tests revealed critically low blood sugar levels and elevated fasting insulin and C-peptide. Despite a normal abdominal CT, a PET-CT scan identified an exophytic pancreatic lesion with metastases to retroperitoneal lymph nodes, and malignancy was confirmed by histopathological examination. This case highlights the necessity of considering insulinoma in the differential diagnosis of unexplained hypoglycemia. Accurate and timely diagnosis, along with appropriate imaging and management, is crucial for effective treatment and improved patient outcomes.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Glinides
Diabetes: Symptoms, Diagnosis, and Complications

